Simultaneous combined intravenous recombinant tissue plasminogen activator and endovascular therapy for hyperacute middle cerebral artery m1 occlusion. [electronic resource]
Producer: 20110712Description: 115-22 p. digitalISSN:- 1591-0199
- Acute Disease
- Aged
- Angioplasty -- adverse effects
- Combined Modality Therapy
- Female
- Humans
- Infarction, Middle Cerebral Artery -- drug therapy
- Injections, Intravenous
- Male
- Middle Aged
- Prospective Studies
- Recombinant Proteins -- administration & dosage
- Thrombolytic Therapy -- adverse effects
- Tissue Plasminogen Activator -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.